Benoist
Alain Benoist, Franconville FR
Patent application number | Description | Published |
---|---|---|
20090082393 | New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them - Compounds of formula (I): | 03-26-2009 |
20090131668 | 4-oxo-4,6,7,8-Tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds - Compound of formula (I): | 05-21-2009 |
Bruno Benoist, Seysses FR
Caroline C. Benoist, Nashville, TN US
Patent application number | Description | Published |
---|---|---|
20130165392 | HEPATOCYTE GROWTH FACTOR MIMICS AS THERAPEUTIC AGENTS - Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, neurodegenerative disease, diabetes and metabolic syndrome, cancer, and defective wound healing. | 06-27-2013 |
20140051633 | Hepatocyte Growth Factor Mimics as Therapeutic Agents - Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia (e.g. Alzheimer's) and Parkinson's disease. | 02-20-2014 |
20140088004 | Hepatocyte Growth Factor Mimics as Therapeutic Agents - Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, neurodegenerative disease, diabetes and metabolic syndrome, cancer, and defective wound healing. | 03-27-2014 |
20140094413 | HEPATOCYTE GROWTH FACTOR (HGF) MIMICS AS THERAPEUTIC AGENTS - Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, Alzheimer's disease, Parkinson's disease, amyotrphic lateral sclerosis, and other neurodegenerative diseases, spinal cord injury, traumatic brain injury, diabetes and metabolic syndrome, cancer, and defective wound healing. | 04-03-2014 |
Christophe Benoist, Linars FR
Patent application number | Description | Published |
---|---|---|
20090103280 | Screen Supporting Device Provided With Screen Illuminating Light Sources - A device for displaying an image has a screen, a support structure with support elements for supporting the screen, and a plurality of light sources. Each support element is in contact with the screen at a contact area. Each light source illuminates an illuminated area on the screen. The light sources are positioned such that illuminated areas generated by light sources adjoining one another are overlapping and thus create an overlapping area. The contact areas between support elements and the screen are superimposed on the overlapping areas. | 04-23-2009 |
Christophe Benoist, Brookline, MA US
Patent application number | Description | Published |
---|---|---|
20140112898 | UNIQUE POPULATION OF REGULATORY T CELLS THAT REGULATE TISSUE REGENERATION AND WOUND HEALING - A unique type of regulatory T cell has been identified in muscle. These tissue-regenerative Treg cells play a role in regulating wound healing. These cells, as well as agents that control their differentiation and/or activity and agents produced by the cells, can be used to modulate wound healing and the differentiation of muscle cells. | 04-24-2014 |
Christophe O. Benoist, Brookline, MA US
Patent application number | Description | Published |
---|---|---|
20100166669 | METHODS OF IMAGING INFLAMMATION IN PANCREATIC ISLETS - Described are non-invasive methods for imaging pancreatic inflammation in living mammals using Magnetic Nanoparticle Probes (MNPs). | 07-01-2010 |
20110044939 | REGULATORY T CELLS IN ADIPOSE TISSUE - Methods of preventing, delaying, or reducing the development or severity of obesity-associated disorders, including administering Fat-specific regulatory T cells, or administering factors secreted by said T cells. | 02-24-2011 |
20110165144 | METHODS FOR TREATING RHEUMATOID ARTHRITIS - Provided are methods of treating rheumatoid arthritis by inhibiting Neuromedin U signalling. | 07-07-2011 |
Fleury Benoist, Vincennes FR
Patent application number | Description | Published |
---|---|---|
20110002507 | Obstacle detection procedure for motor vehicle - The present invention concerns an obstacle detection procedure within the area surrounding a motor vehicle. | 01-06-2011 |
Guillaume Benoist, Chartres FR
Patent application number | Description | Published |
---|---|---|
20080226717 | Sublingual Coated Tablet - The present invention relates to a sublingual coated tablet and to a method for the preparation thereof. The tablet includes a core devoid of a pharmaceutically active substance, and a coating including at least one active substance. The preferred active substance is an opioid analgesic. | 09-18-2008 |
Sebire Pierre Benoist, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20100298017 | Closed Subscriber Group Measurement Reporting - An adjacent cell is determined to be a private cell, and then a measurement report of it that includes an identifier for the private cell is sent from a UE to the UE's serving network node. Methods, apparatus and computer readable media storing a program are detailed. In exemplary non-limiting embodiments: the identifier is at least a TA ID for the private cell's CSG network, where the UE receives the TA ID over a broadcast channel/system information of the serving network node; the TA ID may be a short TA ID received over a primary broadcast channel of the serving network node; the identifier comprises the TA ID and either a LI cell ID or a CSG cell ID; and if the UE is not a member of the CSG network it the measurement report only in response to a command received from the serving network node. | 11-25-2010 |
Thierry Benoist, Ranco IT
Patent application number | Description | Published |
---|---|---|
20110148643 | TSUNAMI WARNING SYSTEM AND METHOD FOR PROVIDING TSUNAMI WARNINGS - A tsunami warning system ( | 06-23-2011 |
Thomas Benoist, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20120319204 | Triggerable Bidirectional Semiconductor Device - A triggerable bidirectional semiconductor device has two terminals and at least one gate. The device comprises, within a layer of silicon on insulator, a central semiconductor zone incorporating the at least one gate and comprising a central region having a first conductivity type, two intermediate regions having a second conductivity type respectively arranged on either side of and in contact with the central region, two semiconductor end zones respectively arranged on either side of the central zone, each end zone comprising two end regions having opposite types of conductivity, in contact with the adjacent intermediate region, the two end regions of each end zone being mutually connected electrically in order to form the two terminals of the device. | 12-20-2012 |
20130214326 | Bidirectional Semiconductor Device for Protection Against Electrostatic Discharges, Usable on Silicon on Insulator - A device includes, within a layer of silicon on insulator, a central semiconductor zone including a central region having a first type of conductivity, two intermediate regions having a second type of conductivity opposite to that of the first one, respectively disposed on either side of and in contact with the central region in order to form two PN junctions, two semiconductor end zones respectively disposed on either side of the central zone, each end zone comprising two end regions of opposite types of conductivity, in contact with the adjacent intermediate region, the two end regions of each end zone being mutually connected electrically in order to form the two terminals of the device. | 08-22-2013 |
Thomas-Medhi Benoist, Grenoble FR
William Benoist, Germantown, TN US
Patent application number | Description | Published |
---|---|---|
20110106173 | Anchor Assembly With Directionally Controlled Saddle Adjustment And Transversely Adjustable Receiver - A bone anchor assembly includes a receiver extending along a central longitudinal axis between a proximal end and an opposite distal end and a bone anchor extending from the receiver. The receiver includes a distal portion defining a receptacle opening at the distal end and a pair of arms extending from the distal portion along the central longitudinal axis on opposite sides of a passage. The receiver includes a saddle that is adjustable in the receiver in one plane to accommodate the angle of placement of the connecting element through the receiver. The receiver is adjustable in another plane that is transverse to the adjustment plane of the saddle to better position the receiver to receive the connecting element. The adjustable saddle and receiver reduce the bending or contouring of the connecting element that may be required to position the connecting element in the receiver. | 05-05-2011 |
William Brent Benoist, Germantown, TN US
Patent application number | Description | Published |
---|---|---|
20110230866 | DELIVERY DEVICE FOR IMPLANTABLE MONITOR - A system, device, and method for placing a capsule for sensing one or more parameters of a patient by anchoring the capsule to a tissue at a specific site and releasing the capsule from the device, using a single actuator operated during a single motion. As an example, a delivery device may anchor the capsule to the tissue site and release the capsule from the delivery device during a single motion of the actuator. This allows a user to place the capsule by interacting with only a single actuator through one type of motion, thus making delivery of the capsule more reliable and user-friendly. | 09-22-2011 |
20130066385 | CONNECTING ELEMENT REDUCTION INSTRUMENT AND METHODS FOR USING SAME - A reduction instrument is releasably engageable with a bone anchor and structured to reduce a connecting element into a receiving member of the bone anchor. The reduction instrument includes a first member, a second member pivotably coupled to the first member, an offset anchor engaging portion, and a reduction member axially displaceable relative to the first and second members. A passage may be positioned between the first and second members which includes a laterally enlarged portion positioned proximal to the anchor engaging portion. The reduction member may include a guide member movable along a first interior surface of the first member and facing the second member as the reduction member is axially displaced relative to the first and second members. Methods of use are disclosed. | 03-14-2013 |